Candel stock plunges 20% following Phase 2 data release
Shares of Candel Therapeutics (NASDAQ:CADL) fell 20% Tuesday after the company reported final overall survival data from a ...
Research upends scientific understanding of how anticancer drugs work
Research by UMass Chan Medical School scientists Sharon Cantor, Ph.D., and Jenna M. Whalen, Ph.D., poses a new explanation ...